Selected research
Market Structure
Global Genome Chip Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Genome Chip market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Genome Chip is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Genome Chip include Illumnia, Thermo Fisher, Agilent, Scienion AG, SCHOTT, Arrayit, Standard BioTools, QIAGEN and GeneCopoeia, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Genome Chip market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Genome Chip and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Genome Chip sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Genome Chip market size, projected growth trends, production technologies, key applications, and end-use industries.
Genome Chip Segment by Company
Illumnia
Thermo Fisher
Agilent
Scienion AG
SCHOTT
Arrayit
Standard BioTools
QIAGEN
GeneCopoeia
Oxford Gene Technology
Axela Biosciences
Genome Chip Segment by Type
Oligonucleotide DNA Chip
Complementary DNA Chip
Genome Chip Segment by Application
Research Centers
Clinical
Commercial Molecular Diagnostic
Others
Genome Chip Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Chip market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Chip and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Chip.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Genome Chip market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genome Chip manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genome Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Genome Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oligonucleotide DNA Chip
- Complementary DNA Chip
Applications
- Research Centers
- Clinical
- Commercial Molecular Diagnostic
- Others
Companies covered
- Illumnia
- Thermo Fisher
- Agilent
- Scienion AG
- SCHOTT
- Arrayit
- Standard BioTools
- QIAGEN
- GeneCopoeia
- Oxford Gene Technology
- Axela Biosciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Genome Chip Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Genome Chip Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Genome Chip Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Genome Chip Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Genome Chip Market Dynamics
- 2.1 Genome Chip Industry Trends
- 2.2 Genome Chip Industry Drivers
- 2.3 Genome Chip Industry Opportunities and Challenges
- 2.4 Genome Chip Industry Restraints
3 Genome Chip Market by Manufacturers
- 3.1 Global Genome Chip Revenue by Manufacturers (2021-2026)
- 3.2 Global Genome Chip Sales by Manufacturers (2021-2026)
- 3.3 Global Genome Chip Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Genome Chip Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Genome Chip Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Genome Chip Manufacturers, Product Type & Application
- 3.7 Global Genome Chip Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Genome Chip Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Genome Chip Players Market Share by Revenue in 2025
- 3.8.3 2025 Genome Chip Tier 1, Tier 2, and Tier 3
4 Genome Chip Market by Type
- 4.1 Genome Chip Type Introduction
- 4.1.1 Oligonucleotide DNA Chip
- 4.1.2 Complementary DNA Chip
- 4.2 Global Genome Chip Sales by Type
- 4.2.1 Global Genome Chip Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Genome Chip Sales by Type (2021-2032)
- 4.2.3 Global Genome Chip Sales Market Share by Type (2021-2032)
- 4.3 Global Genome Chip Revenue by Type
- 4.3.1 Global Genome Chip Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Genome Chip Revenue by Type (2021-2032)
- 4.3.3 Global Genome Chip Revenue Market Share by Type (2021-2032)
5 Genome Chip Market by Application
- 5.1 Genome Chip Application Introduction
- 5.1.1 Research Centers
- 5.1.2 Clinical
- 5.1.3 Commercial Molecular Diagnostic
- 5.1.4 Others
- 5.2 Global Genome Chip Sales by Application
- 5.2.1 Global Genome Chip Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Genome Chip Sales by Application (2021-2032)
- 5.2.3 Global Genome Chip Sales Market Share by Application (2021-2032)
- 5.3 Global Genome Chip Revenue by Application
- 5.3.1 Global Genome Chip Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Genome Chip Revenue by Application (2021-2032)
- 5.3.3 Global Genome Chip Revenue Market Share by Application (2021-2032)
6 Global Genome Chip Sales by Region
- 6.1 Global Genome Chip Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Genome Chip Sales by Region (2021-2032)
- 6.2.1 Global Genome Chip Sales by Region (2021-2026)
- 6.2.2 Global Genome Chip Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Genome Chip Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Genome Chip Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Genome Chip Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Genome Chip Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Genome Chip Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Genome Chip Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Genome Chip Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Genome Chip Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Genome Chip Revenue by Region
- 7.1 Global Genome Chip Revenue by Region
- 7.1.1 Global Genome Chip Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Genome Chip Revenue by Region (2021-2026)
- 7.1.3 Global Genome Chip Revenue by Region (2027-2032)
- 7.1.4 Global Genome Chip Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Genome Chip Revenue (2021-2032)
- 7.2.2 North America Genome Chip Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Genome Chip Revenue (2021-2032)
- 7.3.2 Europe Genome Chip Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Genome Chip Revenue (2021-2032)
- 7.4.2 Asia-Pacific Genome Chip Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Genome Chip Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Genome Chip Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Illumnia
- 8.1.1 Illumnia Company Information
- 8.1.2 Illumnia Business Overview
- 8.1.3 Illumnia Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Illumnia Genome Chip Product Portfolio
- 8.1.5 Illumnia Recent Developments
- 8.2 Thermo Fisher
- 8.2.1 Thermo Fisher Company Information
- 8.2.2 Thermo Fisher Business Overview
- 8.2.3 Thermo Fisher Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Thermo Fisher Genome Chip Product Portfolio
- 8.2.5 Thermo Fisher Recent Developments
- 8.3 Agilent
- 8.3.1 Agilent Company Information
- 8.3.2 Agilent Business Overview
- 8.3.3 Agilent Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Agilent Genome Chip Product Portfolio
- 8.3.5 Agilent Recent Developments
- 8.4 Scienion AG
- 8.4.1 Scienion AG Company Information
- 8.4.2 Scienion AG Business Overview
- 8.4.3 Scienion AG Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Scienion AG Genome Chip Product Portfolio
- 8.4.5 Scienion AG Recent Developments
- 8.5 SCHOTT
- 8.5.1 SCHOTT Company Information
- 8.5.2 SCHOTT Business Overview
- 8.5.3 SCHOTT Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 SCHOTT Genome Chip Product Portfolio
- 8.5.5 SCHOTT Recent Developments
- 8.6 Arrayit
- 8.6.1 Arrayit Company Information
- 8.6.2 Arrayit Business Overview
- 8.6.3 Arrayit Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Arrayit Genome Chip Product Portfolio
- 8.6.5 Arrayit Recent Developments
- 8.7 Standard BioTools
- 8.7.1 Standard BioTools Company Information
- 8.7.2 Standard BioTools Business Overview
- 8.7.3 Standard BioTools Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Standard BioTools Genome Chip Product Portfolio
- 8.7.5 Standard BioTools Recent Developments
- 8.8 QIAGEN
- 8.8.1 QIAGEN Company Information
- 8.8.2 QIAGEN Business Overview
- 8.8.3 QIAGEN Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 QIAGEN Genome Chip Product Portfolio
- 8.8.5 QIAGEN Recent Developments
- 8.9 GeneCopoeia
- 8.9.1 GeneCopoeia Company Information
- 8.9.2 GeneCopoeia Business Overview
- 8.9.3 GeneCopoeia Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 GeneCopoeia Genome Chip Product Portfolio
- 8.9.5 GeneCopoeia Recent Developments
- 8.10 Oxford Gene Technology
- 8.10.1 Oxford Gene Technology Company Information
- 8.10.2 Oxford Gene Technology Business Overview
- 8.10.3 Oxford Gene Technology Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Oxford Gene Technology Genome Chip Product Portfolio
- 8.10.5 Oxford Gene Technology Recent Developments
- 8.11 Axela Biosciences
- 8.11.1 Axela Biosciences Company Information
- 8.11.2 Axela Biosciences Business Overview
- 8.11.3 Axela Biosciences Genome Chip Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Axela Biosciences Genome Chip Product Portfolio
- 8.11.5 Axela Biosciences Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Genome Chip Value Chain Analysis
- 9.1.1 Genome Chip Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Genome Chip Production Mode & Process
- 9.2 Genome Chip Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Genome Chip Distributors
- 9.2.3 Genome Chip Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst